Inscrivez-vous pour interagir sur nos forums actifs pour discuter avec des investisseurs aux idées similaires.

S'inscrire

OSA

ProSomnus (OSA)

ProSomnus Inc

De:

Actualités Réglementées

Mots clefs:

Trier par:

Actualités Non-réglementées

Showing the most relevant articles for your search:NASDAQ:OSA

Date	Heure	Source	Titre	Symbole	Société
26/03/2024	21h05	GlobeNewswire Inc.	ProSomnus Reports Record Fourth Quarter and Fiscal Year 2023 Financial Results	NASDAQ:OSA	ProSomnus Inc
18/03/2024	12h12	IH Market News	Anticipation Builds on Wall Street for Federal Reserve’s Upcoming Policy Moves; WTI and Brent See Upticks	NASDAQ:OSA	ProSomnus Inc
16/03/2024	01h01	GlobeNewswire Inc.	ProSomnus Reschedules Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call	NASDAQ:OSA	ProSomnus Inc
22/02/2024	14h30	GlobeNewswire Inc.	ProSomnus Reports Successful Pilot Study Validation of Next Generation Remote Patient Monitoring Device for Obstructive Sleep Apnea	NASDAQ:OSA	ProSomnus Inc
20/02/2024	22h05	GlobeNewswire Inc.	ProSomnus Announces Fourth Quarter and Fiscal Year 2023 Investor and Business Update Call and Participation at the 36th Annual ROTH Conference in March 2024	NASDAQ:OSA	ProSomnus Inc
30/01/2024	14h00	GlobeNewswire Inc.	ProSomnus Severe Indication 510(k) Submission Accepted for Review by the FDA	NASDAQ:OSA	ProSomnus Inc
29/01/2024	14h00	GlobeNewswire Inc.	ProSomnus Poised to Support Obstructive Sleep Apnea Patients Following Discontinuation of Philips Respironics OSA Devices	NASDAQ:OSA	ProSomnus Inc
08/01/2024	14h00	GlobeNewswire Inc.	ProSomnus Comments on Insurance Coverage Policy Update for Obstructive and Central Sleep Apnea	NASDAQ:OSA	ProSomnus Inc
19/12/2023	14h00	GlobeNewswire Inc.	Data Published by Cureus Journal of Medical Science Shows Successful Treatment of Obstructive Sleep Apnea with ProSomnus Precision Oral Appliance Devices	NASDAQ:OSA	ProSomnus Inc
09/11/2023	22h17	GlobeNewswire Inc.	ProSomnus, the Leading Non-CPAP Obstructive Sleep Apnea Therapy, Reports Record Third Quarter 2023 Financial Results	NASDAQ:OSA	ProSomnus Inc
31/10/2023	21h05	GlobeNewswire Inc.	ProSomnus Announces Third Quarter 2023 Investor Call and Business Update	NASDAQ:OSA	ProSomnus Inc
03/10/2023	22h05	GlobeNewswire Inc.	ProSomnus Announces Participation in the 2023 Roth Capital Healthcare Opportunities Conference	NASDAQ:OSA	ProSomnus Inc
21/09/2023	14h30	GlobeNewswire Inc.	ProSomnus Raises $10 Million To Fuel Growth and Optimize Operations	NASDAQ:OSA	ProSomnus Inc
14/09/2023	14h30	GlobeNewswire Inc.	ProSomnus Precision Obstructive Sleep Apnea Devices to be Featured in Scientific Abstracts and Podium Presentations at Upcoming Medical Conferences	NASDAQ:OSA	ProSomnus Inc
23/08/2023	14h00	GlobeNewswire Inc.	Updated Clinical Trial Data Indicates Precision Oral Appliance Therapy with ProSomnus Devices is Non-Inferior to CPAP Therapy for the Treatment of Moderate to Severe Obstructive Sleep Apnea	NASDAQ:OSA	ProSomnus Inc
03/08/2023	14h09	GlobeNewswire Inc.	ProSomnus Reports Record Second Quarter 2023 Top-Line Financial Results	NASDAQ:OSA	ProSomnus Inc
13/07/2023	14h00	GlobeNewswire Inc.	ProSomnus to Design Head-to-Head Clinical Trial vs. Hypoglossal Nerve Stimulation	NASDAQ:OSA	ProSomnus Inc
06/07/2023	14h29	GlobeNewswire Inc.	ProSomnus Announces Second Quarter 2023 Investor Call and Business Update	NASDAQ:OSA	ProSomnus Inc
28/06/2023	14h00	GlobeNewswire Inc.	71% of Self-identified Snorers Have Never Consulted a Healthcare Professional	NASDAQ:OSA	ProSomnus Inc
08/06/2023	22h08	GlobeNewswire Inc.	Data Presented at the 2023 SLEEP Annual Meeting Strengthens Evidence for ProSomnus Precision Oral Appliance Therapy for the Treatment of Obstructive Sleep Apnea	NASDAQ:OSA	ProSomnus Inc
30/05/2023	14h00	GlobeNewswire Inc.	Data Presented at the 2023 American Academy of Dental Sleep Medicine and the American Thoracic Society Meetings Further Validate ProSomnus Precision Oral Appliance Therapy for the Treatment of Obstructive Sleep Apnea	NASDAQ:OSA	ProSomnus Inc
09/05/2023	22h00	GlobeNewswire Inc.	ProSomnus Reports First Quarter 2023 Financial Results	NASDAQ:OSA	ProSomnus Inc
26/04/2023	15h00	GlobeNewswire Inc.	ProSomnus Announces Q1 2023 Investor Call and Participation in Upcoming Investor Conferences	NASDAQ:OSA	ProSomnus Inc
24/04/2023	22h05	GlobeNewswire Inc.	Study to be Presented at European Respiratory Society and European Sleep Research Society’s Sleep and Breathing 2023 Conference Demonstrates Efficacy of ProSomnus Precision Oral Appliances	NASDAQ:OSA	ProSomnus Inc
18/04/2023	14h00	GlobeNewswire Inc.	ProSomnus® Announces Publication of Four Accepted Abstracts in the Journal of Dental Sleep Medicine in Advance of Annual Meeting	NASDAQ:OSA	ProSomnus Inc
05/04/2023	14h00	GlobeNewswire Inc.	ProSomnus® Receives Additional U.S. Utility Patent Covering Iterative Titration Technology for Company’s Novel Precision Sleep Apnea Medical Devices	NASDAQ:OSA	ProSomnus Inc
30/03/2023	22h05	GlobeNewswire Inc.	ProSomnus Reports Fourth Quarter and Fiscal Year 2022 Financial Results	NASDAQ:OSA	ProSomnus Inc
21/03/2023	13h00	GlobeNewswire Inc.	ProSomnus® Receives Patent Allowance Covering Automated Manufacturing Process for Company’s Novel Precision Sleep Apnea Medical Devices	NASDAQ:OSA	ProSomnus Inc
16/03/2023	21h05	GlobeNewswire Inc.	ProSomnus to Host Investor Call and Report Fourth Quarter and Full Year 2022 Financial Results on March 30, 2023	NASDAQ:OSA	ProSomnus Inc
10/03/2023	14h00	GlobeNewswire Inc.	ProSomnus® Announces Acceptance of Abstract at European Respiratory Society and European Sleep Research Society’s Sleep and Breathing 2023 Conference	NASDAQ:OSA	ProSomnus Inc

Showing the most relevant articles for your search:NASDAQ:OSA

JP Morgan Chase

Lvmh Moet Hennessy Louis...

Societe Generale

Delayed Upgrade Clock

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales